Wordt geladen...
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-A(xxx)b) in colorectal cancer patients predicts tumour VEGF-A ratios
Purpose: Bevacizumab as an adjunct to chemotherapy improves survival for some patients with metastatic colorectal cancer. Immunohistochemical staining of samples from the registration ECOG E3200 trial of bevacizumab with FOLFOX demonstrated that only patients with carcinomas expressing low levels of...
Bewaard in:
| Gepubliceerd in: | Am J Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529627/ https://ncbi.nlm.nih.gov/pubmed/26269767 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|